VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2069 INJECTION FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ADULT PATIENTS OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA

Contact Us

Products

• Core Product
• API
• Formulation
• Quality Assurance

Science

• R&D
• Solutions

About Us

• Who are we
• Our history
• Main production base
• Governance and Leadership